Bayer AG
XETRA:BAYN
Bayer AG
XETRA:BAYN
Price:
27.935 EUR
-0.69%
Updated:
May 3, 2024
Bayer AG
Additional Paid In Capital
|
Bayer AG
Additional Paid In Capital Peer Comparison
Comparables:
ATAI
MRK
93M1
DMP
PSG
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bayer AG
XETRA:BAYN
|
Additional Paid In Capital
€18.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Additional Paid In Capital
$794.8m
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck KGaA
XETRA:MRK
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
MPH Health Care AG
XETRA:93M1
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Additional Paid In Capital
€100.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Additional Paid In Capital
€38.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Additional Paid In Capital?
Additional Paid In Capital
18.3B
EUR
18.3B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Additional Paid In Capital amounts to 18.3B EUR.
What is Bayer AG's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
11%
11%
Over the last year, the Additional Paid In Capital growth was 0%.
You don't have any saved screeners yet
